CME Group Inc. (NASDAQ:CME) had its price objective lifted by equities researchers at Deutsche Bank AG from $115.00 to $116.00 in a report released on Wednesday, StockTargetPrices.com reports. The firm presently has a “buy” rating on the stock. Deutsche Bank AG’s price objective points to a potential upside of 11.61% from the company’s current price.
A number of other brokerages have also commented on CME. JPMorgan Chase & Co. increased their price objective on shares of CME Group from $99.00 to $106.00 and gave the stock an “overweight” rating in a report on Friday, July 29th. Zacks Investment Research raised shares of CME Group from a “sell” rating to a “hold” rating in a report on Thursday, June 30th. Credit Agricole SA decreased their price objective on shares of CME Group from $100.00 to $95.00 and set an “underperform” rating on the stock in a report on Thursday, July 14th. Keefe, Bruyette & Woods increased their price objective on shares of CME Group from $99.00 to $103.00 and gave the stock a “market perform” rating in a report on Friday, July 29th. Finally, Barclays PLC cut their target price on shares of CME Group from $100.00 to $99.00 and set an “equal weight” rating on the stock in a research report on Friday, July 29th. Two investment analysts have rated the stock with a sell rating, six have assigned a hold rating and six have assigned a buy rating to the company’s stock. CME Group has an average rating of “Hold” and an average price target of $103.18.
CME Group (NASDAQ:CME) traded down 0.22% on Wednesday, hitting $103.70. 401,448 shares of the stock traded hands. The stock has a market capitalization of $35.14 billion, a P/E ratio of 26.19 and a beta of 0.83. CME Group has a 12-month low of $81.87 and a 12-month high of $110.35. The company’s 50 day moving average price is $106.81 and its 200-day moving average price is $99.29.
CME Group (NASDAQ:CME) last issued its quarterly earnings data on Thursday, July 28th. The company reported $1.14 EPS for the quarter, topping analysts’ consensus estimates of $1.11 by $0.03. CME Group had a net margin of 38.22% and a return on equity of 6.83%. The firm had revenue of $906 million for the quarter, compared to analyst estimates of $897.84 million. During the same quarter in the prior year, the firm earned $0.95 EPS. The company’s revenue was up 10.5% on a year-over-year basis. Analysts predict that CME Group will post $4.44 EPS for the current year.
The business also recently announced a quarterly dividend, which was paid on Monday, September 26th. Shareholders of record on Friday, September 9th were issued a dividend of $0.60 per share. The ex-dividend date was Wednesday, September 7th. This represents a $2.40 annualized dividend and a yield of 2.31%. CME Group’s dividend payout ratio (DPR) is currently 60.61%.
In other news, insider Kimberly S. Taylor sold 2,300 shares of the firm’s stock in a transaction that occurred on Monday, August 1st. The shares were sold at an average price of $102.58, for a total transaction of $235,934.00. Following the completion of the transaction, the insider now directly owns 103,789 shares of the company’s stock, valued at approximately $10,646,675.62. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director James E. Oliff sold 1,000 shares of the firm’s stock in a transaction that occurred on Friday, July 15th. The stock was sold at an average price of $102.30, for a total transaction of $102,300.00. The disclosure for this sale can be found here. Company insiders own 0.61% of the company’s stock.
Several institutional investors have recently modified their holdings of CME. Tower Research Capital LLC TRC boosted its position in CME Group by 447.6% in the second quarter. Tower Research Capital LLC TRC now owns 1,621 shares of the company’s stock valued at $157,000 after buying an additional 1,325 shares in the last quarter. Parametrica Management Ltd purchased a new position in CME Group during the second quarter valued at $212,000. Private Advisor Group LLC purchased a new position in CME Group during the second quarter valued at $214,000. Ranger International Management LP purchased a new position in CME Group during the second quarter valued at $219,000. Finally, Evercore Wealth Management LLC boosted its position in CME Group by 19.5% in the second quarter. Evercore Wealth Management LLC now owns 2,270 shares of the company’s stock valued at $221,000 after buying an additional 370 shares in the last quarter. 80.29% of the stock is owned by institutional investors.
About CME Group
CME Group Inc is a provider of products across all major asset classes, based on interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals. The Company’s products include both exchange-traded and privately negotiated futures and options contracts and swaps. The Company connects buyers and sellers together through its CME Globex electronic trading platform across the globe and its open outcry trading facilities in Chicago and New York City.
Receive News & Ratings for CME Group Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group Inc. and related companies with MarketBeat.com's FREE daily email newsletter.